Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Avidian Wealth Solutions LLC grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 8,148 shares of the biopharmaceutical company’s stock after purchasing an additional 259 shares during the quarter. Avidian […]
U.S. Capital Wealth Advisors LLC raised its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 314.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 83,070 shares of the biopharmaceutical company’s stock after purchasing an additional 63,009 shares during […]
Swiss National Bank trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,896,300 shares of the biopharmaceutical company’s stock after selling 115,900 shares during the period. Swiss […]
MONECO Advisors LLC grew its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,307 shares of the biopharmaceutical company’s stock after acquiring an additional 688 shares during the quarter. […]
Weaver C. Barksdale & Associates Inc. reduced its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 20.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 25,746 shares of the biopharmaceutical company’s stock after selling 6,786 shares during the quarter. Gilead Sciences makes up about 2.0% of Weaver C. Barksdale & Associates Inc.’s […]